Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 0 | $0.00 | $0.00 | $0.00 |
Heart Test Laboratories, Inc. last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 0 for the quarter and had revenue of 18,600 for the year. Heart Test Laboratories, Inc. has generated $-19 earnings per share over the last year ($-18.74 diluted earnings per share) and currently has a price-to-earnings ratio of -460.85. Heart Test Laboratories, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, January 30th, 2023 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
12/16/2024 | Q2 2025 | -$0.00 | $0 | |||
09/12/2024 | Q1 2025 | -$2.64 | $0 | |||
07/29/2024 | Q4 2024 | -$2.73 | $0 | |||
03/14/2024 | Q3 2024 | -$3.06 | $14,700 | |||
12/14/2023 | Q2 2024 | -$15.98 | $3,900 | |||
09/14/2023 | Q1 2024 | -$13.23 | $0 | |||
07/18/2023 | Q4 2023 | -$16.47 | $5.14 M | |||
03/16/2023 | Q3 2023 | -$16.47 | $1,950 | |||
12/15/2022 | Q2 2023 | -$22.39 | $0 | |||
09/12/2022 | Q1 2023 | -$30.55 | $3,200 | |||
07/29/2022 | Q4 2022 | -$64.04 | $4,149 | |||
01/31/2022 | Q3 2022 | -$37.27 | $2,740 | |||
10/30/2021 | Q2 2022 | -$31.23 | $0 | |||
07/30/2021 | Q1 2022 | -$15.14 | $7,484 | |||
04/29/2021 | Q4 2021 | -$25.70 | $14,950 |
Heart Test Laboratories, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, January 30th, 2023 based off last year's report dates.
The conference call for Heart Test Laboratories, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Heart Test Laboratories, Inc.'s latest earnings report can be read online.
Heart Test Laboratories, Inc. (:HSCSW) has a recorded annual revenue of $18,600.
Heart Test Laboratories, Inc. (:HSCSW) has a recorded net income of $18,600. Heart Test Laboratories, Inc. has generated $-18.74 earnings per share over the last four quarters.
Heart Test Laboratories, Inc. (:HSCSW) has a price-to-earnings ratio of -460.85 and price/earnings-to-growth ratio is -8.21.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED